ArticleCancers2025

Synergistic Inhibition of Drug Resistant KRAS Mutant Non-Small Cell Lung Cancer by Co-Targeting AXL and SRC.

Soumavo Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.